$SAGE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sage Therapeutics, Inc.. Get notifications about new insider transactions in Sage Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Buy | M | 56.27 | 700 | 39,389 | 700 | 0 to 700 |
May 10 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Sell | S | 166.14 | 15,000 | 2,492,100 | 0 | 15 K to 0 (-100.00 %) |
May 10 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Buy | M | 28.63 | 15,000 | 429,450 | 15,000 | 0 to 15 K |
May 06 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | M | 8.92 | 8,000 | 71,360 | 1,309 | ||
May 06 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Sell | S | 162.22 | 8,000 | 1,297,760 | 4,235 | 12.2 K to 4.2 K (-65.39 %) | |
May 06 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Buy | M | 8.92 | 8,000 | 71,360 | 12,235 | 4.2 K to 12.2 K (+188.90 %) | |
Mar 22 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.02 | 1,967 | 316,726 | 122,400 | 124.4 K to 122.4 K (-1.58 %) | |
Mar 22 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.05 | 2,919 | 470,105 | 124,367 | 127.3 K to 124.4 K (-2.29 %) | |
Mar 22 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.04 | 2,993 | 481,993 | 127,286 | 130.3 K to 127.3 K (-2.30 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.35 | 13,047 | 2,105,133 | 130,279 | 143.3 K to 130.3 K (-9.10 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.32 | 13,096 | 2,112,647 | 143,326 | 156.4 K to 143.3 K (-8.37 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.20 | 16,182 | 2,608,538 | 156,422 | 172.6 K to 156.4 K (-9.38 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.32 | 14,321 | 2,310,264 | 172,604 | 186.9 K to 172.6 K (-7.66 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.01 | 875 | 140,884 | 186,925 | 187.8 K to 186.9 K (-0.47 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.02 | 800 | 128,816 | 187,800 | 188.6 K to 187.8 K (-0.42 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.14 | 1,200 | 193,368 | 188,600 | 189.8 K to 188.6 K (-0.63 %) | |
Mar 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.01 | 900 | 144,909 | 189,800 | 190.7 K to 189.8 K (-0.47 %) | |
Mar 11 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 0.45 | 4,723 | 2,125 | 0 | |
Mar 11 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 0.45 | 4,723 | 2,125 | 6,136 | 1.4 K to 6.1 K (+334.25 %) |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 30,600 | 0 | 193,300 | 162.7 K to 193.3 K (+18.81 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 30,600 | 0 | 162,700 | 132.1 K to 162.7 K (+23.16 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 30,600 | 0 | 132,100 | 101.5 K to 132.1 K (+30.15 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 30,600 | 0 | 101,500 | 70.9 K to 101.5 K (+43.16 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 122,400 | 0 | 119,295 | 241.7 K to 119.3 K (-50.64 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.00 | 500 | 80,500 | 70,900 | 71.4 K to 70.9 K (-0.70 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.00 | 500 | 80,500 | 71,400 | 71.9 K to 71.4 K (-0.70 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.00 | 500 | 80,500 | 71,900 | 72.4 K to 71.9 K (-0.69 %) | |
Feb 27 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.00 | 500 | 80,500 | 72,400 | 72.9 K to 72.4 K (-0.69 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 162.00 | 200 | 32,400 | 72,900 | 73.1 K to 72.9 K (-0.27 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.37 | 643 | 103,761 | 73,100 | 73.7 K to 73.1 K (-0.87 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.62 | 500 | 80,812 | 73,743 | 74.2 K to 73.7 K (-0.67 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 162.00 | 200 | 32,400 | 74,243 | 74.4 K to 74.2 K (-0.27 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.02 | 12,388 | 1,994,716 | 74,443 | 86.8 K to 74.4 K (-14.27 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.02 | 12,044 | 1,939,325 | 86,831 | 98.9 K to 86.8 K (-12.18 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.02 | 12,510 | 2,014,360 | 98,875 | 111.4 K to 98.9 K (-11.23 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 161.02 | 12,519 | 2,015,809 | 111,385 | 123.9 K to 111.4 K (-10.10 %) | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 241,695 | 0 | 241,695 | 0 to 241.7 K | |
Feb 20 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Gift | G | 0.00 | 241,695 | 0 | 272,777 | 514.5 K to 272.8 K (-46.98 %) | |
Feb 15 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | A | 157.63 | 19,000 | 2,994,970 | 19,000 | |
Feb 15 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 157.63 | 24,500 | 3,861,935 | 24,500 | |
Feb 15 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 157.63 | 50,000 | 7,881,500 | 50,000 | |
Feb 08 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 150.00 | 22,948 | 3,442,200 | 941 | 23.9 K to 941 (-96.06 %) |
Jan 24 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | M | 8.92 | 7,500 | 66,900 | 9,309 | ||
Jan 24 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Sell | S | 134.81 | 7,500 | 1,011,075 | 4,235 | 11.7 K to 4.2 K (-63.91 %) | |
Jan 24 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Buy | M | 8.92 | 7,500 | 66,900 | 11,735 | 4.2 K to 11.7 K (+177.10 %) | |
Jan 24 2019 | SAGE | Sage Therapeutics, ... | Barrett Elizabeth | Option Exercise | A | 137.29 | 20,000 | 2,745,800 | 20,000 | ||
Jan 24 2019 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 137.29 | 20,000 | 2,745,800 | 20,000 | ||
Jan 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 10,000 | 4,500 | 221,987 | |
Jan 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 10,000 | 4,500 | 62,115 | 52.1 K to 62.1 K (+19.19 %) |
Jan 04 2019 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 89.33 | 878 | 78,432 | 878 | ||
Dec 11 2018 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 47.70 | 23,100 | 1,101,870 | 23,100 | |
Dec 11 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 47.70 | 6,600 | 314,820 | 6,600 | |
Dec 11 2018 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | See Remarks | Option Exercise | A | 47.70 | 9,240 | 440,748 | 9,240 | |
Dec 11 2018 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 47.70 | 6,600 | 314,820 | 6,600 | |
Dec 11 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 47.70 | 7,425 | 354,173 | 7,425 | |
Aug 23 2018 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Gift | G | 0.00 | 65 | 0 | 4,235 | 4.3 K to 4.2 K (-1.51 %) | |
Aug 23 2018 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Gift | G | 0.00 | 700 | 0 | 4,300 | 5 K to 4.3 K (-14.00 %) | |
Jun 20 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 0.45 | 800 | 360 | 67,949 | |
Jun 20 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 0.45 | 800 | 360 | 26,826 | 26 K to 26.8 K (+3.07 %) |
Jun 08 2018 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Option Exercise | A | 154.06 | 10,000 | 1,540,600 | 10,000 | ||
Jun 08 2018 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 154.06 | 10,000 | 1,540,600 | 10,000 | ||
Jun 08 2018 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | A | 154.06 | 10,000 | 1,540,600 | 10,000 | ||
Jun 08 2018 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 154.06 | 10,000 | 1,540,600 | 10,000 | ||
May 08 2018 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | M | 8.92 | 7,000 | 62,440 | 16,809 | ||
May 08 2018 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Sell | S | 154.00 | 7,000 | 1,078,000 | 5,000 | 12 K to 5 K (-58.33 %) | |
May 08 2018 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Buy | M | 8.92 | 7,000 | 62,440 | 12,000 | 5 K to 12 K (+140.00 %) | |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 142.69 | 900 | 128,421 | 38,345 | 39.2 K to 38.3 K (-2.29 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 141.26 | 2,300 | 324,898 | 39,245 | 41.5 K to 39.2 K (-5.54 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 140.38 | 7,818 | 1,097,491 | 41,545 | 49.4 K to 41.5 K (-15.84 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 146.14 | 500 | 73,070 | 49,363 | 49.9 K to 49.4 K (-1.00 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 145.10 | 600 | 87,060 | 49,863 | 50.5 K to 49.9 K (-1.19 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 144.06 | 500 | 72,030 | 50,463 | 51 K to 50.5 K (-0.98 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 142.50 | 900 | 128,250 | 50,963 | 51.9 K to 51 K (-1.74 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 141.51 | 2,500 | 353,775 | 51,863 | 54.4 K to 51.9 K (-4.60 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 150.68 | 500 | 75,340 | 54,363 | 54.9 K to 54.4 K (-0.91 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 149.54 | 635 | 94,958 | 54,863 | 55.5 K to 54.9 K (-1.14 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 145.58 | 700 | 101,906 | 55,498 | 56.2 K to 55.5 K (-1.25 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 144.71 | 2,601 | 376,391 | 56,198 | 58.8 K to 56.2 K (-4.42 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 143.90 | 4,700 | 676,330 | 58,799 | 63.5 K to 58.8 K (-7.40 %) |
Apr 25 2018 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Sell | S | 142.84 | 2,999 | 428,377 | 63,499 | 66.5 K to 63.5 K (-4.51 %) |
Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 168.28 | 24,000 | 4,038,650 | 302,817 | 326.8 K to 302.8 K (-7.34 %) |
Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 169.25 | 35,000 | 5,923,600 | 326,817 | 361.8 K to 326.8 K (-9.67 %) |
Apr 04 2018 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 145.77 | 31,500 | 4,591,755 | 31,500 | |
Apr 04 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 145.77 | 27,000 | 3,935,790 | 27,000 | |
Apr 04 2018 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 145.77 | 90,000 | 13,119,300 | 90,000 | |
Mar 08 2018 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Sell | S | 172.00 | 58,139 | 9,999,908 | 632,712 | 690.9 K to 632.7 K (-8.42 %) | |
Feb 20 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 510,554 | 0 | 37,362 | 547.9 K to 37.4 K (-93.18 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 20,000 | 9,000 | 111,432 | |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 20,000 | 9,000 | 22,948 | 2.9 K to 22.9 K (+678.43 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 180.11 | 1,400 | 252,154 | 2,948 | 4.3 K to 2.9 K (-32.20 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 179.61 | 7,859 | 1,411,555 | 4,348 | 12.2 K to 4.3 K (-64.38 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 178.33 | 6,923 | 1,234,579 | 12,207 | 19.1 K to 12.2 K (-36.19 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 177.48 | 9,100 | 1,615,068 | 19,130 | 28.2 K to 19.1 K (-32.24 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 176.53 | 11,057 | 1,951,892 | 28,230 | 39.3 K to 28.2 K (-28.14 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 175.03 | 2,461 | 430,749 | 39,287 | 41.7 K to 39.3 K (-5.89 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 174.35 | 2,200 | 383,570 | 41,748 | 43.9 K to 41.7 K (-5.01 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 173.09 | 1,200 | 207,708 | 43,948 | 45.1 K to 43.9 K (-2.66 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 171.80 | 1,200 | 206,160 | 45,148 | 46.3 K to 45.1 K (-2.59 %) |
Jan 12 2018 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Sell | S | 170.67 | 600 | 102,402 | 46,348 | 46.9 K to 46.3 K (-1.28 %) |
Dec 26 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 50,000 | 22,500 | 232,552 | |
Dec 26 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 50,000 | 22,500 | 51,226 | 1.2 K to 51.2 K (+4,078.30 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 12,753 | 5,739 | 282,552 | |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 110,247 | 49,611 | 295,305 | |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 155.00 | 12,753 | 1,976,715 | 1,226 | 14 K to 1.2 K (-91.23 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 12,753 | 5,739 | 13,979 | 1.2 K to 14 K (+1,040.21 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 162.59 | 599 | 97,391 | 1,226 | 1.8 K to 1.2 K (-32.82 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 162.08 | 5,000 | 810,400 | 1,825 | 6.8 K to 1.8 K (-73.26 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 160.36 | 13,049 | 2,092,538 | 6,825 | 19.9 K to 6.8 K (-65.66 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 159.53 | 22,334 | 3,562,943 | 19,874 | 42.2 K to 19.9 K (-52.91 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 158.21 | 33,301 | 5,268,551 | 42,208 | 75.5 K to 42.2 K (-44.10 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 157.48 | 27,152 | 4,275,897 | 75,509 | 102.7 K to 75.5 K (-26.45 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 156.55 | 71,823 | 11,243,891 | 102,661 | 174.5 K to 102.7 K (-41.16 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 155.48 | 36,989 | 5,751,050 | 174,484 | 211.5 K to 174.5 K (-17.49 %) |
Dec 22 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 110,247 | 49,611 | 211,473 | 101.2 K to 211.5 K (+108.91 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 163.93 | 1,021 | 167,373 | 94,259 | 95.3 K to 94.3 K (-1.07 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 162.21 | 700 | 113,547 | 95,280 | 96 K to 95.3 K (-0.73 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 161.40 | 6,187 | 998,582 | 95,980 | 102.2 K to 96 K (-6.06 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 160.12 | 21,410 | 3,428,169 | 102,167 | 123.6 K to 102.2 K (-17.33 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 159.46 | 8,734 | 1,392,724 | 123,577 | 132.3 K to 123.6 K (-6.60 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 158.18 | 16,748 | 2,649,199 | 132,311 | 149.1 K to 132.3 K (-11.24 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 157.27 | 3,700 | 581,899 | 149,059 | 152.8 K to 149.1 K (-2.42 %) |
Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 156.31 | 1,500 | 234,465 | 152,759 | 154.3 K to 152.8 K (-0.97 %) |
Nov 08 2017 | SAGE | Sage Therapeutics, ... | Nayak Asha | Option Exercise | A | 65.49 | 20,883 | 1,367,628 | 20,883 | ||
Sep 27 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 545,000 | 0 | 547,916 | 1.1 M to 547.9 K (-49.87 %) |
Jul 19 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 800,000 | 0 | 1,092,916 | 1.9 M to 1.1 M (-42.26 %) |
Jun 09 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
Jun 08 2017 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
Jun 08 2017 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
Jun 08 2017 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
Jun 08 2017 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
May 04 2017 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 73.43 | 185,000 | 13,584,550 | 185,000 | |
Feb 17 2017 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Buy | J | 3.15 | 2,174 | 6,848 | 690,851 | 688.7 K to 690.9 K (+0.32 %) | |
Feb 08 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 47.70 | 40,000 | 1,908,000 | 40,000 | |
Feb 08 2017 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 47.70 | 40,000 | 1,908,000 | 40,000 | |
Feb 08 2017 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 47.70 | 140,000 | 6,678,000 | 140,000 | |
Feb 08 2017 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | A | 47.70 | 40,000 | 1,908,000 | 40,000 | |
Feb 08 2017 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 47.70 | 45,000 | 2,146,500 | 45,000 | |
Feb 08 2017 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | See Remarks | Option Exercise | A | 47.70 | 56,000 | 2,671,200 | 56,000 | |
Jan 24 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 1,892,916 | 2.9 M to 1.9 M (-34.57 %) |
Jan 13 2017 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Sell | S | 53.92 | 10,000 | 539,200 | 66,498 | 76.5 K to 66.5 K (-13.07 %) |
Dec 19 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | M | 8.92 | 1,900 | 16,948 | 165,138 | |
Dec 19 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Payment of Exercise | F | 48.99 | 346 | 16,951 | 1,554 | 1.9 K to 1.6 K (-18.21 %) |
Dec 19 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Buy | M | 8.92 | 1,900 | 16,948 | 1,900 | 0 to 1.9 K |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | General Counsel | Option Exercise | A | 28.63 | 10,000 | 286,300 | 40,000 | |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Anderson Thomas | See Remarks | Option Exercise | A | 38.25 | 12,600 | 481,950 | 59,500 | |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO, Secretary and ... | Option Exercise | A | 38.25 | 14,400 | 550,800 | 68,000 | |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | See Remarks | Option Exercise | A | 38.25 | 43,200 | 1,652,400 | 324,000 | |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 38.25 | 14,400 | 550,800 | 68,000 | |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 38.25 | 10,800 | 413,100 | 51,000 | |
Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 154,259 | 154.5 K to 154.3 K (-0.16 %) |